These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3840021)

  • 1. Studies on the fluorescence labeling of human red blood cell membrane ghosts with 4'-(9-acridinylamino)methanesulfon-m-anisidide.
    Wong A; Crooke ST
    Biochem Pharmacol; 1985 Sep; 34(18):3265-73. PubMed ID: 3840021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formation of the thiol adducts of 4'-(9-acridinylamino)methanesulfon-m-anisidide and their binding to deoxyribonucleic acid.
    Wong A; Huang CH; Hwang SM; Prestayko AW; Crooke ST
    Biochem Pharmacol; 1986 May; 35(10):1655-62. PubMed ID: 3754750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of deoxyribonucleic acid breakage induced by 4'-(9-acridinylamino)methanesulfon-m-anisidide and copper: role for cuprous ion and oxygen free radicals.
    Wong A; Huang CH; Crooke ST
    Biochemistry; 1984 Jun; 23(13):2946-52. PubMed ID: 6087883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of the active species in deoxyribonucleic acid breakage induced by 4'-(9-acridinylamino)methanesulfon-m-anisidide and copper.
    Wong A; Cheng HY; Crooke ST
    Biochem Pharmacol; 1986 Apr; 35(7):1071-8. PubMed ID: 3754443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deoxyribonucleic acid breaks produced by 4'-(9-acridinylamino)methanesulfon-m-anisidide and copper.
    Wong A; Huang CH; Crooke ST
    Biochemistry; 1984 Jun; 23(13):2939-45. PubMed ID: 6205684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced DNA break formation and cytotoxicity of the topoisomerase II drug 4'-(9'-acridinylamino)methanesulfon-m-anisidide when combined with hyperthermia in human and rodent cell lines.
    Kampinga HH; van den Kruk G; Konings AW
    Cancer Res; 1989 Apr; 49(7):1712-7. PubMed ID: 2538233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic interaction between methotrexate and 4'-(9-acridinylamino)methanesulfon-M-anisidide in the rabbit.
    Lee YJ; Chan KK
    Cancer Res; 1988 Sep; 48(18):5106-11. PubMed ID: 3409236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of conjugation and cleavage products in the thiolytic metabolism of the anticancer drug 4'-(9-acridinylamino)methanesulfon-m-anisidide.
    Przybylski M; Cysyk RL; Shoemaker D; Adamson RH
    Biomed Mass Spectrom; 1981 Oct; 8(10):485-91. PubMed ID: 6895335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of 4'-(9-acridinylamino)methanesulphon-m-anisidine) action by verapamil.
    Darkin S; Ralph RK
    Cancer Lett; 1986 Jan; 30(1):25-33. PubMed ID: 3080225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The action of the DNA intercalating agents 4'-(9-acridinylamino) methanesulphon-m-anisidide and 1,4-bis(butylamino) benzo[g]phthalazine in U-937 human promonocytic cells: relationship between cell cycle and differentiation.
    Pérez C; Campayo L; Navarro P; García-Bermejo L; Aller P
    Biochem Pharmacol; 1994 Jul; 48(1):75-82. PubMed ID: 7519013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amsacrine-induced lesions in DNA and their modulation by novobiocin and 2,4-dinitrophenol.
    Shibuya ML; Buddenbaum WE; Don AL; Utsumi H; Suciu D; Kosaka T; Elkind MM
    Cancer Res; 1991 Jan; 51(2):573-80. PubMed ID: 1985775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of 7-hydroxymethotrexate formation by amsacrine.
    Bremnes RM; Smeland E; Willassen NP; Wist E; Aarbakke J
    Cancer Chemother Pharmacol; 1991; 28(5):377-83. PubMed ID: 1914082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transport of AMSA drugs into cells.
    Darkin S; Ralph RK
    FEBS Lett; 1985 Oct; 190(2):349-53. PubMed ID: 3930297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quenching of DNA-ethidium fluorescence by amsacrine and other antitumor agents: a possible electron-transfer effect.
    Baguley BC; Le Bret M
    Biochemistry; 1984 Feb; 23(5):937-43. PubMed ID: 6546881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase II clinical study of mAMSA in small cell carcinoma of the lung.
    Dady PJ; Sappino AP; Rudd A; Smith IE
    Cancer Chemother Pharmacol; 1981; 6(2):195-6. PubMed ID: 6273006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A human small cell lung carcinoma cell line, resistant to 4'-(9-acridinylamino)-methanesulfon-m-anisidide and cross-resistant to camptothecin with a high level of topoisomerase I.
    Prost S; Riou G
    Biochem Pharmacol; 1994 Aug; 48(5):975-84. PubMed ID: 8093110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrathecally administered m-AMSA in the rhesus monkey.
    Gormley P; Riccardi R; O'Neill D; Poplack D
    Cancer Drug Deliv; 1984; 1(2):101-7. PubMed ID: 6549572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Copper-dependent oxidative and topoisomerase II-mediated DNA cleavage by a netropsin/4'-(9-acridinylamino)methanesulfon-m-anisidide combilexin.
    Henichart JP; Waring MJ; Riou JF; Denny WA; Bailly C
    Mol Pharmacol; 1997 Mar; 51(3):448-61. PubMed ID: 9058600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term inhibition of DNA synthesis and the persistence of trapped topoisomerase II complexes in determining the toxicity of the antitumor DNA intercalators mAMSA and mitoxantrone.
    Fox ME; Smith PJ
    Cancer Res; 1990 Sep; 50(18):5813-8. PubMed ID: 2168281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence that mAMSA induces topoisomerase action.
    Marshall B; Darkin S; Ralph RK
    FEBS Lett; 1983 Sep; 161(1):75-8. PubMed ID: 6309576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.